ROCKWELL MEDICAL, INC. Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
ROCKWELL MEDICAL, INC. (RMTI) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 0 shares for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-03.
Discontinued › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2015-03-03
- ROCKWELL MEDICAL, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2014-03-31 was 0.00 shares.
- ROCKWELL MEDICAL, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2013-03-31 was 0.00 shares.
- ROCKWELL MEDICAL, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2014 was 0.00 shares.
- ROCKWELL MEDICAL, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2013 was 0.00 shares.
- ROCKWELL MEDICAL, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2012 was 0.00 shares.
- ROCKWELL MEDICAL, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2011 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 12 month |
|---|---|---|
| 2014-12-31 | 0.00 shares 10-K · filed 2015-03-03 | |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-12 | |
| 2013-12-31 | 0.00 shares 10-K · filed 2015-03-03 | |
| 2013-03-31 | 0.00 shares 10-Q · filed 2014-05-12 | |
| 2012-12-31 | 0.00 shares 10-K · filed 2015-03-03 | |
| 2011-12-31 | 0.00 shares 10-K · filed 2014-03-07 | |
| 2010-12-31 | 0.00 shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |